Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Celecoxib Combined With R-CHOP Versus R-CHOP in CD5+ DLBCL
NCT07494565Phase 2Recruiting
- Sponsor
- Sun Yat-sen University
- Start
- Mar 2026
- Primary completion
- Mar 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of celecoxib oral solution in diffuse large B-cell lymphoma (DLBCL), sponsored by Sun Yat-sen University. Started Mar 2026; status: recruiting.
02
Drugs
celecoxib oral solution
03
Conditions
diffuse large B-cell lymphoma (DLBCL)
Beyond the preview
Go deeper on NCT07494565.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07494565.